Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice

Denuja Karunakaran; Adam W Turner; Anne-Claire Duchez; Sebastien Soubeyrand; Adil Rasheed; David Smyth; David P Cook; Majid Nikpay; Joshua W Kandiah; Calvin Pan; Michele Geoffrion; Richard Lee; Ludovic Boytard; Hailey Wyatt; My-Anh Nguyen; Paulina Lau; Markku Laakso; Bhama Ramkhelawon; Marcus Alvarez; Kirsi H Pietiläinen; Päivi Pajukanta; Barbara C Vanderhyden; Peter Liu; Scott B Berger; Peter J Gough; John Bertin; Mary-Ellen Harper; Aldons J Lusis; Ruth McPherson; Katey J Rayner

doi:10.1038/s42255-020-00309-z

Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice

Nat Metab. 2020 Oct;2(10):1181. doi: 10.1038/s42255-020-00309-z.

Authors

Denuja Karunakaran^{1

2

3}, Adam W Turner⁴, Anne-Claire Duchez⁵, Sebastien Soubeyrand⁴, Adil Rasheed⁵, David Smyth⁶, David P Cook⁷, Majid Nikpay⁴, Joshua W Kandiah⁵, Calvin Pan⁸, Michele Geoffrion⁵, Richard Lee⁹, Ludovic Boytard¹⁰, Hailey Wyatt⁵, My-Anh Nguyen⁵, Paulina Lau⁴, Markku Laakso¹¹, Bhama Ramkhelawon¹⁰, Marcus Alvarez¹², Kirsi H Pietiläinen¹³, Päivi Pajukanta¹², Barbara C Vanderhyden⁷, Peter Liu⁶, Scott B Berger¹⁴, Peter J Gough¹⁴, John Bertin¹⁴, Mary-Ellen Harper¹⁵, Aldons J Lusis⁸, Ruth McPherson^{4

15}, Katey J Rayner^{16

17}

Affiliations

¹ Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. d.karunakaran@imb.uq.edu.au.
² Cardiac Function Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. d.karunakaran@imb.uq.edu.au.
³ Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia. d.karunakaran@imb.uq.edu.au.
⁴ Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
⁵ Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
⁶ Cardiac Function Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
⁷ Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada.
⁸ David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
⁹ Cardiovascular Antisense Drug Discovery Group, Ionis Pharmaceuticals, Carlsbad, CA, USA.
¹⁰ New York University Langone Medical Center, New York, NY, USA.
¹¹ Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
¹² Department of Human Genetics, and Institute for Precision Health, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
¹³ Obesity Research Unit, Research Program for Clinical and Molecular Metabolism and Obesity Center, Endocrinology, Abdominal Center, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
¹⁴ Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA.
¹⁵ Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
¹⁶ Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. krayner@ottawaheart.ca.
¹⁷ Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada. krayner@ottawaheart.ca.

PMID: 33033401
DOI: 10.1038/s42255-020-00309-z

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum